-
Mashup Score: 0
Plus Adam Fein’s PBM numbers, a bizarre Leqembi forecast from CMS, gene therapy reimbursement, and more …
Source: costcurve.beehiiv.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1
Plus a must-read STAT piece on how to think about GLP-1s
Source: costcurve.beehiiv.comCategories: General Medicine News, Future of MedicineTweet-
This @IQVIA_global piece is awfully damning to the big #PBM co's. They're costing us an extra $6B!! HT @brianreid - You've GOT to subscribe to his Cost Curve newsletter! IQVIA Makes Clear Where the Blame Should Fall for the Broken Humira Biosims Market https://t.co/mi3KrEUKCt https://t.co/BJ7tuu37B4
-
-
Mashup Score: 2
And the net-price nuggets from yesterday’s Senate hearing that went (almost) unnoticed
Source: costcurve.beehiiv.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1Bernie Will Get CEOs to Capitol Hill; NC Will Not Get Obesity Meds to Its Beneficiaries - 3 month(s) ago
And other reasons why the next 10 days in DrugPricingLand are going to be so intense
Source: costcurve.beehiiv.comCategories: General Medicine News, Future of MedicineTweet
Insightful piece on unintended (read: OPPOSITE) consequences of drug pricing legislation: Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties by @brianreid https://t.co/XgZZBae08n